Z-0825-2021 Class II Ongoing

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-0825-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 7, 2020 and is designated Class II. Reason for recall: The sodium and/or calcium levels in these concentrates were below the manufacturing specifications. The recall status is ongoing. Affected quantity: 592 drums.

Recall details

Product Type
Devices
Report Date
Jan 20, 2021
Initiation Date
Nov 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
592 drums

Product description

NaturaLyte Liquid Acid concentrate drums, Model Number 13-2251-0 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Reason for recall

The sodium and/or calcium levels in these concentrates were below the manufacturing specifications.

Distribution pattern

US Nationwide distribution.

Code information

Lot Numbers: 20LXAC070 20LXAC103 20NXAC021 20LXAC100 20LXAC026 20LXAC027 20LXAC028 20LXAC029 20LXAC065 20LXAC067 20LXAC071 20NXAC001 20NXAC019 20NXAC020 20NXAC029 Additional affected lots as of 3/17/21: 20LXAC103 20LXAC082 20LXAC025 20LXAC081 20LXAC083

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0825-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0825-2021. Report a data issue: hello@regdatalab.com.